Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian CancerJoanna B. Madalinska, Neil K. Aaronson, Judith Hollenstein et al.|Journal of Clinical Oncology|2005Cited by 239
The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-OophorectomyJoanna B. Madalinska, Neil K. Aaronson, Marc van Beurden et al.|Journal of Clinical Oncology|2006Cited by 215
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyBrenda Hermsen, Matti A. Rookus, R.I. Olivier et al.|British Journal of Cancer|2007Cited by 153
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, Joanne A. de Hullu, M.A.D.W. de Jong et al.|BMC Cancer|2015Cited by 106
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, Angela H.E.M. Maas et al.|JAMA Oncology|2021Cited by 78